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Objectives: The prevalence of resistance genes in two important anaerobic genera, Bacteroides and
Prevotella, was assessed by applying PCR speciﬁcally directed to genes of interest.
Methods: A total of 101 Bacteroides spp. and 99 Prevotella spp. human clinical isolates were identiﬁed
using MALDI-TOF MS. The presence of the resistance genes cfxA, cepA, cﬁA, tetQ, ermF and nim, was
assessed. Prevalence of resistance genes was compared with the phenotypic resistance against
amoxicillin, clindamycin, meropenem and metronidazole.
Results: Even though the majority of the Bacteroides isolates (95.0%) showed resistance towards amox-
icillin, only 52/101 of the isolates harboured one of the resistance genes, accounting for this resistance.
Within the genus Prevotella the presence of cfxA (50/99) almost perfectly matched the amoxicillin
resistance (48/99). No difference in prevalence of the ermF gene (16/101 and 9/99) and clindamycin
resistance (16/101 and 10/99) was observed within Bacteroides and Prevotella, respectively. Two isolates
of Prevotella were resistant to metronidazole. One harboured the nim gene. One metronidazole-
susceptible isolate of Bacteroides harboured a nim gene. Within the Bacteroides and Prevotella genera,
6/101 strains and 5/99 isolates harboured three different resistance genes, respectively, among them tetQ.
TetQ is often located on a conjugative transposon, increasing the chance of horizontal gene transfer
between isolates.
Conclusions: An unknown mechanism in Bacteroides non-fragilis isolates causes resistance to b-lactam
antibiotics. The fact that the prevalence of the tetQ gene among Prevotella is increasing and the existence
of isolates harbouring three resistance genes are worrisome developments. A.C.M. Veloo, Clin Microbiol
Infect 2019;25:1156.e9e1156.e13
© 2019 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and
Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Members of the phylum Bacteroidetes are a major part of the
human commensal oral and gut microbiota. Two anaerobic genera
from this phylum, Bacteroides and Prevotella, are regularly isolated
fromhuman clinical specimens and are known to play an important
role in mixed anaerobic infections. Members of the Bacteroides
group are the most prevalent anaerobic bacteria in infections [1].
As among aerobic bacteria, the antibiotic resistance in anaerobic
bacteria is increasing. Decades ago the resistance to clindamycin
among the Bacteroides group isolates was 6% [2] compared within 1, 9713 GZ Groningen, the
o).
Ltd on behalf of European Society
g/licenses/by-nc-nd/4.0/).21% in 2015 [3]. Resistance genes among anaerobic bacteria can be
exchanged by horizontal gene transfer. Conjugative transposons
(CTn) and/or plasmids harbour one or several resistance genes that
can be transferred under conditions of, for example, low concen-
trations of antibiotic [4]. Themost studied CTn in anaerobic bacteria
is CTnDOT, encountered in several Bacteroides species. This CTn
harbours a tetracycline resistance gene, tetQ, regularly accompa-
nied by the ermF gene. The latter causes resistance to clindamycin.
The conjugative transfer of CTnDOT is a complex series of events,
triggered by exposing the bacterial cell to low concentrations of
tetracycline. About 80% of Bacteroides strains are now resistant to
tetracycline, as a consequence of its intensive use in the past [5].
The most important feature for a bacterium to protect itself
against b-lactam antibiotics is the production of b-lactamases.
Garcia et al. [6], described that in Bacteroides the presence of a cfxA
gene is the most frequent indicator for b-lactamase production.of Clinical Microbiology and Infectious Diseases. This is an open access article under
A.C.M. Veloo et al. / Clinical Microbiology and Infection 25 (2019) 1156.e9e1156.e13 1156.e10Furthermore, b-lactamases can be produced by the cepA gene,
which has only been found in Bacteroides fragilis strains [6,7]. The
expression of either the cfxA or cepA gene results in high resistance
to penicillins and cephalosporins. A worrisome development is the
production of metallo-b-lactamases by Bacteroides strains. This
enzyme, encoded by the cﬁA gene, cannot be inhibited by b-lacta-
mase inhibitors. Similar to the cepA gene, the cﬁA gene is strictly
restricted to strains of B. fragilis [8].
A limited number of studies have been performed on the
prevalence of antibiotic-resistance genes in Bacteroides strains
isolated from human clinical specimens [7,9,10]. Most studies focus
on the prevalence of the cﬁA gene in B. fragilis [8,11]. To our
knowledge, studies focusing on the prevalence of antibiotic-
resistance genes in the genus Prevotella are scarce.
In this study, we determined the prevalence of resistance genes
in Bacteroides and Prevotella isolates obtained from human clinical
specimens, at the University Medical Centre, Groningen, the
Netherlands. Besides the most prevalent resistance genes against
antibiotics used nowadays, we also determined the prevalence of
the tetQ gene. In this study the prevalence of cfxA, tetQ, ermF and
nim genes in Prevotella and, additionally, of the cepA and cﬁA genes
in Bacteroides clinical isolates, was assessed.
Material and methods
Bacterial strains
A total of 101 Bacteroides and 99 Prevotella isolates, isolated from
a variety of human clinical specimens, were included in this study.
All Bacteroides isolates and most Prevotella isolates (n ¼ 77) were
collected, consecutively, in 2016; some Prevotella isolates were
collected in 2015 (n ¼ 11) and 2017 (n ¼ 11) to obtain a similar
number of isolates as for the Bacteroides group. Isolates were
revived from the e80C freezer, subcultured on Brucella blood agar
(Mediaproducts, Groningen, the Netherlands), supplemented with
haemin (5 mg/L) and vitamin K (1 mg/L), and incubated at 37C for
48 hours in an anaerobic jar (Mart Microbiology, Drachten, the
Netherlands) or anaerobic cabinet (Don Whitley, Bingley, UK). In
both cases the anaerobic environment was created from the same
gas mixture (80% N2, 10% CO2, 10% H2). An anaerobic indicator
(Oxoid, Badhoevedorp, the Netherlands) was included. Isolates
were identiﬁed using matrix assisted laser desorption ionization
time-of-ﬂight mass spectrometry (MALDI-TOF MS; Bruker Dalto-
niks, Bremen, Germany), as described previously [12]. Obtained log
scores were interpreted as advised by the manufacturer, e.g. a log
score 2 was recorded as an identiﬁcation with high conﬁdence,
log score1.7 and <2 as an identiﬁcationwith low conﬁdence and a
log score <1.7 as no reliable identiﬁcation. Since MALDI-TOF MS is
unable to differentiate between Bacteroides ovatus and Bacteroides
xylanisolvens or between Bacteroides vulgatus and Bacteroides dorei
[13], these species were listed as B. ovatus/xylanisolvens and
B. vulgatus/dorei, respectively. No patient consent or approval from
the ethics committee was required as isolates were obtained during
routine microbiological diagnostics and upon admission patients
can indicate if they do not want leftover material/isolates being
used for research and/or improvement of diagnostic procedures.
Antibiotic susceptibility testing
For each strain, the antibiotic susceptibility proﬁle for amoxi-
cillin, clindamycin, metronidazole and meropenem was deter-
mined using an Etest (Biomerieux, Marcy-l’Etoile, France). Brieﬂy,
Brucella blood agar was conﬂuently inoculated with a bacterial
suspension of 1 McFarland prepared in saline. After applying an
Etest strip, plates were incubated in an anaerobic environment, asmentioned above, at 37C. After 48 hours of incubation, the MIC
value was determined as advised by the manufacturer. The sus-
ceptibility testing was part of the diagnostic procedure in our
laboratory. Resistance was determined according to the EUCAST
guidelines (v6.0).
Prevalence of resistance genes
Isolates belonging to the genus Bacteroides were tested for the
presence of cfxA, cepA, cﬁA, tetQ, ermF and nim antibiotic-resistance
genes and isolates belonging to the genus Prevotellawere tested for
the presence of cfxA, tetQ, ermF and nim genes using targeted PCR.
As a positive control, a Bacteroides strain and a Prevotella strain
were used in which antibiotic-resistance genes were known to be
present, as assessed by whole genome sequencing. An overview of
the primers used in the PCR is shown in the Supplementary
material (Table S1).
For PCR, DNA was obtained by suspending bacterial colonies in
DNAse/RNAse-free water. The PCR mastermix consisted of 100 mL
HotStart-Taq mastermix (100 U/mL DNA polymerase, 400 mM of
each dNTP; Qiagen, Hilden, Germany), 4 mL of each of the primers
(10 mM; Eurogentec, Luik, Belgium) and 84 mL DNAse/RNAse-free
water. For each PCR 24 mL PCR mastermix and 1 mL DNA suspen-
sion were used, yielding an end concentration of 5 mM per primer.
The PCR reactions were run in a T100™ Thermal cycler (Bio-Rad,
Hercules, CA, USA), using the conditions presented in the Supple-
mentary material (Table S1). Strains harbouring the cﬁA gene were
also checked for the presence of an insertion sequence (IS) element




The most prevalent species within the Bacteroides group were
B. fragilis (n ¼ 38), Bacteroides thetaiotaomicron (n ¼ 21), B. ovatus/
xylanisolvens (n ¼ 11) and B. vulgatus/dorei (n ¼ 11). Among the
genus Prevotella the most prevalent species were Prevotella mela-
ninogenica (n ¼ 21), Prevotella bivia (n ¼ 17) and Prevotella buccae
(n ¼ 13) (Tables 1 and 2).
Antibiotic susceptibility and prevalence of resistance genes
Only 2 of the 38 tested B. fragilis isolates (5.3%) were mer-
openem resistant, and the cﬁA genewas present in six of the strains
(15.8%; Table 1). In one isolate an IS-element, upstream of the cﬁA
gene, was present. Of the six isolates harbouring the cﬁA gene, two
showed complete resistance to meropenem and four were inter-
mediate resistant (data not shown). The isolate harbouring both the
cﬁA gene and the IS-element showed complete resistance to
meropenem (MIC >32 mg/mL).
Most of the Bacteroides isolates were resistant to amoxicillin.
Among the 38 B. fragilis isolates, 34 were was resistant to amoxi-
cillin (89.5%), and the cepA and cﬁA genes (with and without IS-
element) were present in 31 and 6 isolates (81.6% and 15.8%),
respectively. At least one of these two genes was found in 37 of the
tested isolates (97.4%). The cfxA gene was found in 14 of the 63
tested non-fragilis species of Bacteroides. However, 48 isolates of B.
non-fragiliswere resistant to amoxicillin, but did not harbour a cfxA
gene.
Resistance to clindamycin differed among the Bacteroides
species. In most cases the prevalence of the ermF gene was similar
to the number of isolates showing resistance to clindamycin.
Table 1
The number of resistant isolates and the percentage resistance against different antibiotics and the prevalence of corresponding resistance genes in the different species of
Bacteroides
Species (n) Resistant strains, n (%) Prevalence of antibiotic-resistance genes, n (%)
Amoxicillin Meropenem Clindamyin Metronidazole cfxA cepA cﬁA IS-element tetQ ermF nim
Breakpoint (mg/L) R>2 R>8 R>4 R>4
B. cellulosilyticus (n ¼ 2) 2 (100) 0 1 (50.0) 0 0 0 0 nab 2 (100) 0 0
B. clarus (n ¼ 2) 2 (100) 0 0 0 1 (50.0) 0 0 na 2 (100) 0 0
B. fragilis (n ¼ 38) 34 (89.5) 2 (5.3) 2 (5.3) 0 1 (2.6) 31 (81.6) 6 (15.8) 1 (2.6) 23 (60.5) 5 (13.2) 0
B. nordii (n ¼ 2) 2 (100) 0 0 0 0 0 0 na 0 0 0
B. ovatus/xylanisolvens (n ¼ 11) 11 (100) 0 6 (54.5) 0 3 (27.3) 0 0 na 6 (54.5) 4 (36.4) 0
B. salyersiae (n ¼ 4) 4 (100) 0 0 0 0 0 0 na 1 (25.0) 0 0
B. stercoris (n ¼ 2) 2 (100) 0 1 (50.0) 0 1 (50.0) 0 0 na 2 (100) 1 (50.0) 0
B. thetaiotaomicron (n ¼ 21) 21 (100) 0 3 (14.3) 0 4 (19.0) 0 0 na 10 (47.6) 2 (9.5) 0
B. uniformis (n ¼ 4) 4 (100) 0 1 (25.0) 0 0 0 0 na 3 (75.0) 1 (25.0) 0
B. vulgatus/dorei (n ¼ 11) 11 (100) 0 2 (18.2) 0 4 (36.4) 0 0 na 8 (72.7) 3 (27.3) 1 (9.1)
Bacteroides spp. (n ¼ 4)a 3 (75.0) 0 0 0 1 (25.0) 0 0 na 2 (50.0) 0 0
Total, n (%) 96 (95.0) 2 (2.0) 16 (15.8) 0 15 (14.9) 31 (30.7) 6 (5.9) 1 (1.0) 59 (58.4) 16 (15.8) 1 (1.0)
a Bacteroides spp. includes B. caccae, B. coagulans, B. intestinalis and B. massiliensis.
b Not applicable.
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showing no resistance to metronidazole. All other tested Bacter-
oides isolates were susceptible to metronidazole and no nim gene
was present.
Of all tested Bacteroides isolates, 59 (58.4%) harboured the tetQ
gene, among these were all isolates of Bacteroides cellulosilyticus,
Bacteroides clarus and Bacteroides stercoris.
None of the 99 tested Prevotella isolates showed resistance to
meropenem. The prevalence of resistance against the other tested
antibiotics differed depending on the Prevotella species (Table 2).
The prevalence of the cfxA gene corresponded with the percentage
of resistance against amoxicillin in six of the tested species whereas
in the other species a difference in phenotypic resistance and
prevalence of the resistance gene was observed.
In general, the prevalence of the ermF gene corresponded with
the percentage of clindamycin-resistant isolates; nine isolates
harboured the ermF gene and ten were phenotypically resistant.
Metronidazole resistance was observed for one isolate of
P. melaninogenica (MIC >256mg/L) and one isolate of P. bivia (MIC 6
mg/L). The nim gene was detected in the metronidazole-resistant
P. bivia isolate. None of the other tested Prevotella isolates
harboured this gene.Table 2
The number of resistant isolates and the percentage of resistance against different antibi
Species (n) Resistant strains (n [%])
Amoxicillin Meropenem Clindamyin
Breakpoint (mg/L) R>2 R>8 R>4
P. baroniae (n ¼ 2) 1 (50.0) 0 0
P. bergensis (n ¼ 3) 2 (66.7) 0 2 (66.7)
P. bivia (n ¼ 17) 9 (52.9) 0 2 (11.8)
P. buccae (n ¼ 13) 5 (38.5) 0 0
P. buccalis (n ¼ 3) 0 0 0
P. copri (n ¼ 2) 1 (50.0) 0 1 (50.0)
P. denticola (n ¼ 7) 4 (57.1) 0 0
P. disiens (n ¼ 4) 1 (25.0) 0 2 (50.0)
P. histicola (n ¼ 2) 1 (50.0) 0 0
P. intermedia (n ¼ 4) 1 (25.0) 0 0
P. jejuni (n ¼ 2) 2 (100) 0 0
P. melaninogenica (n ¼ 21) 14 (66.7) 0 1 (4.8)
P. nigrescens (n ¼ 4) 3 (75.0) 0 1 (25.0)
P. oris (n ¼ 2) 2 (100) 0 0
P. timonensis (n ¼ 6) 1 (16.7) 0 1 (16.7)
Prevotella spp. (n ¼ 7)a 1 (14.3) 0 0
Total, n (%) 48 (48.5) 0 10 (10.1)
a Prevotella spp. includes two Prevotella spp. isolates, and one of P. oralis, P. loescheii, POf the 99 tested Prevotella isolates, 30 harboured the tetQ gene.
Its prevalence was highest in P. bivia and P. bergensis, i.e. 12/17
(70.6%) and 2/3 (66.7%), respectively.
Several Bacteroides isolates harbouredmore than two antibiotic-
resistance genes (Table 3; see Supplementary material, Table S2).
Two B. fragilis isolates harboured the cepA, tetQ and ermF genes. In
addition, two B. ovatus/xylanisolvens, one B. stercoris and one
B. vulgatus/dorei isolate harboured the cfxA, tetQ and ermF genes.
Four Prevotella strains harboured three resistance genes (Table 3;
see Supplementary material Table S3). One P. bergensis, one Pre-
votella disiens and one P. melaninogenica isolate harboured the cfxA,
tetQ and ermF genes. In addition, one isolate of P. bivia harboured
the cfxA, tetQ and nim genes.
Discussion
In this study, we describe the prevalence of antibiotic-resistance
genes in human clinical isolates of Bacteroides and Prevotella spe-
cies, isolated in the Netherlands. Bacteroides fragilis is the most
prevalent anaerobic species isolated from human clinical speci-
mens and also the one studiedmost extensively.Within this species
we encountered a prevalence for the cﬁA and cepA genes of,otics and the prevalence of the corresponding resistance genes in Prevotella isolates
Prevalence of antibiotic-resistance genes, n (%)
Metronidazole cfxA tetQ ermF nim
R>4
0 1 (50.0) 0 0 0
0 2 (66.7) 2 (66.7) 2 (66.7) 0
1 (5.9) 12 (70.6) 12 (70.6) 1 (5.9) 1 (5.9)
0 3 (23.1) 2 (15.4) 1 (7.7) 0
0 1 (33.3) 1 (33.3) 0 0
0 0 1 (50.0) 0 0
0 4 (57.1) 0 0 0
0 3 (75.0) 2 (50.0) 2 (50.0) 0
0 1 (50.0) 1 (50.0) 0 0
0 0 1 (25.0) 0 0
0 1 (50.0) 1 (50.0) 0 0
1 (4.8) 14 (66.7) 2 (9.5) 1 (4.8) 0
0 0 0 1 (25.0) 0
0 2 (100) 1 (50.0) 0 0
0 4 (66.7) 2 (33.3) 1 (16.7) 0
0 2 (28.6) 2 (28.6) 0 0
2 (2.0) 50 (50.5) 30 (30.3) 9 (9.1) 1 (1.0)
. massiliensis, P. dentalis and P. oulorum isolate.
Table 3
Distribution of antibiotic-resistance genes in Bacteroides and Prevotella species, harbouring three different antibiotic-resistance genes
Species (n) cfxA cepA cﬁA IS tetQ ermF nim
Bacteroides fragilis (n ¼ 1) d d þ þ þ d d
Bacteroides fragilis (n ¼ 2) d þ d naa þ þ d
Bacteroides ovatus/xylanisolvens (n ¼ 2) þ d d na þ þ d
Bacteroides stercoris (n ¼ 1) þ d d na þ þ d
Bacteroides vulgatus/dorei (n ¼ 1) þ d d na þ þ d
Prevotella bergensis (n ¼ 1) þ na na na þ þ d
Prevotella bivia (n ¼ 1) þ na na na þ d þ
Prevotella disiens (n ¼ 1) þ na na na þ þ d
Prevotella melaninogenica (n ¼ 1) þ na na na þ þ d
a Not applicable.
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observed resistance against amoxicillin (89.5%) in the isolates of
B. fragilis. Tran et al. [7], observed a prevalence of 90.4% of the cepA
gene in B. fragilis and no cfxA gene, while Eitel et al. [9] reported, for
a European study, prevalences of 78.9% and 14.8%, respectively. In
this study we report a prevalences of 81.6% and 2.6%, respectively.
None of the strains harboured both genes. Gutacker et al. [14]
showed that B. fragilis strains belong to two genetic groups, based
on the presence of cepA and cﬁA: subdivision I, strains harbouring
the cepA gene, and subdivision II, strains harbouring the cﬁA gene.
In this study,15.8% of the B. fragilis strains belonged to subdivision II
and 81.6% to subdivision I. It is noteworthy that in isolates of other
Bacteroides species the prevalence of the cfxA gene was lower than
the observed resistance for amoxicillin. This indicates that within
non-fragilis isolates another antibiotic-resistance gene or mecha-
nism must be present, which is responsible for resistance against
b-lactam antibiotics, as reported by Tran et al. [7]. The fact that
these strains were shown to produce b-lactamase using a ceﬁnase
disc (data not shown), supports this hypothesis.
We report prevalences of 15.8% and 9.1% of the ermF genewithin
the Bacteroides group and Prevotella species, respectively. Boente
et al. [15] reported a similar percentage within B. fragilis strains,
which were isolated in a clinical setting, whereas Tran et al. [7]
reported 28.6%. Within the B. fragilis strains used in this study a
prevalence of 12.8% was observed. Remarkably, the prevalence of
the ermF gene was much higher within the B. ovatus/xylanisolvens
and B. vulgatus/dorei speciesd36.4% and 27.3%, respectively.
The tetQ gene is known to be located on a CTn and can be
associated with the ermF gene on the same CTn [16]. Exposing
strains harbouring this kind of CTn to low concentrations of tetra-
cycline stimulates the transfer of this CTn. This process also triggers
the excision of other mobile elements out of the genome. In this
case not only transfer of the CTn harbouring the tetQ and/or ermF
gene takes place, but also the transfer of other mobile elements
harbouring antibiotic-resistance genes [17]. In this study, the
prevalences of the tetQ gene in Bacteroides and Prevotella were
58.4% and 30.3%, respectively. Often not only the tetQ gene is pre-
sent, but also other antibiotic-resistance genes, cfxA for example.
The cfxA gene is known to be located on a transposon, Tn4555 [18],
as is the nimK gene in P. bivia, described in a previous study [19].
Generally, it is accepted that nim genes play a role in metroni-
dazole resistance, even though the exact resistance mechanism for
this antibiotic remains unknown. In this study we encountered a
metronidazole-susceptible B. vulgatus/dorei strain harbouring a nim
gene, using the described set of primers. Gal and Brazier [20], re-
ported that silent nim genes can become activated when strains
harbouring them are exposed to metronidazole for a prolonged
period of time. A new nim gene, nimJ, was found in two multidrug-
resistant B. fragilis strains [21]. This genewas not detected using the
universal nim primers, as we did in this study. Therefore, we cannot
exclude that more nim genes are present in our set of isolates.Sherrard et al. [22], determined the prevalence of cfxA, tetQ and
ermF in Prevotella strains isolated from individuals with cystic ﬁbrosis
and those without. A prevalence of 45% for the cfxA gene was
observed,which is similar to the prevalence observed in this study, i.e.
50.5%. Furthermore, 4% of the tested strains harboured all three
antibiotic-resistance genes. We found a similar number of isolates
harbouring three antibiotic-resistance genes, randomly divided
among the different species. Arzese et al. [23] reported a prevalence of
20% of the tetQ gene in Prevotella strains, isolated from clinical spec-
imens and healthy individuals, and a prevalence of 8.3% for the ermF
genes in the same collection of strains. As in this study, the presence of
an ermF gene did not always correspond with the phenotypic sus-
ceptibility for clindamycin of isolates. In this study we were con-
frontedwith a higher prevalence of the tetQ gene (30.3%) in Prevotella
isolates solely isolated from human clinical specimens. As the study
by Arzese et al. [23] was performed on strains isolated in 1995e1997,
we hypothesize that the prevalence of the tetQ gene (and hereby also
the prevalence of CTn) among Prevotella strains is increasing.
Unfortunately, not all species are represented by a sufﬁcient
number of strains. Also, the role of efﬂux pumps in unexplained
resistance remains uncertain.
The increase in prevalence and the presence of multiple resis-
tance genes in one isolate warrants further research on this topic,
for example whole genome sequencing of these isolates, especially
since more and more multidrug-resistant anaerobes are reported.
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